Form 10-K/A
BIOTIME INC filed this Form 10-K/A on 04/02/2018
Document Outline
Entire Document (526.6 KB)
Subdocument 1 - 10-K/A
Page 1 - UNITED STATES
Page 2 - EXPLANATORY NOTE
Page 3 - PART IV
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - SIGNATURES
Page 8 - N/A
Subdocument 2 - EX-23.3 - Consents of experts and counsel
Page 1 - Exhibit 23.3
Page 2 - N/A
Subdocument 3 - EX-31 - Certifications required under Section 302 of the Sarbanes-Oxley Act of 2002
Page 1 - Exhibit 31
Page 2 - Exhibit 31
Page 3 - Exhibit 31
Page 4 - N/A
Subdocument 4 - EX-32 - Certifications required under Section 906 of the Sarbanes-Oxley Act of 2002
Page 1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
Page 2 - N/A
Subdocument 5 - EX-99.2 - Exhibits not specifically designated by another number and by investment companies
Page 1 - Exhibit 99.2
Page 2 - ONCOCYTE CORPORATION
Page 3 - ONCOCYTE CORPORATION
Page 4 - ONCOCYTE CORPORATION
Page 5 - ONCOCYTE CORPORATION
Page 6 - ONCOCYTE CORPORATION
Page 7 - ONCOCYTE CORPORATION
Page 8 - Reverse stock split
Page 9 - Level 1
Page 10 - Equipment and furniture
Page 11 - Research and development expenses
Page 12 - Equity-Based Payments to Non-Employees
Page 13 - Net loss per common share
Page 14 - Leases (Topic 842)
Page 15 - 4. Related Party Transactions
Page 16 - Bank Warrants
Page 17 - Future Cash Payments of Loan Payable
Page 18 - N/A
Page 19 - Stock Option Exercises
Page 20 - Options Granted
Page 21 - 8. Income Taxes
Page 22 - Other Income Tax Matters
Page 23 - Wistar License Agreement
Page 24 - Litigation General
Page 25 - N/A